Rachel King - Director, Novavax Inc
As of June 29, 2021
Rachel King Net Worth
- Net worth is estimated to be at least $2.71M
- Owns at least 3,900 units of Novavax Inc stock
Rachel King Trading
- Largest purchase of shares was 700 units , worth over $97.75K on May 21, 2021
- In total has made about 7 transactions over 3 years
- Usually trades in June, with the busiest year in 2021
Rachel King
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Rachel King Mailing Address
- Mailing address is C/o Glycomimetics, Inc. 401 Professional Drive, Suite 250 Gaithersburg MD 20879 MD
Novavax Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Other Earnings Plans or Compensations
|
|---|---|---|---|---|---|---|---|
| Stanley C. Erck Stanley C. Erck | 2020 | $657,181 | $48,086,018 | $44,115,244 | $48,086,018 | $11,400 | $48,086,018 |
| Stanley C. Erck Stanley C. Erck | 2019 | $642,720 | $2,438,562 | $986,660 | $2,438,562 | $11,200 | $2,438,562 |
| Stanley C. Erck Stanley C. Erck | 2018 | $638,040 | $4,158,398 | $3,509,358 | $4,158,398 | $11,000 | $4,158,398 |
| Gregory F. Covino | 2020 | $55,000 | $1,417,774 | $659,967 | $1,417,774 | $8,032 | $1,417,774 |
| Gregory F. Covino | 2019 | $― | $― | $― | $― | $― | $― |
| Gregory F. Covino | 2018 | $― | $― | $― | $― | $― | $― |
| Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. | 2020 | $483,443 | $24,923,376 | $22,859,741 | $24,923,376 | $11,400 | $24,923,376 |
| Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. | 2019 | $470,453 | $1,875,198 | $819,421 | $1,875,198 | $11,200 | $1,875,198 |
| Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. | 2018 | $460,125 | $1,681,456 | $1,131,189 | $1,681,456 | $11,000 | $1,681,456 |
| John J. Trizzino John J. Trizzino | 2020 | $415,892 | $21,327,954 | $19,819,717 | $21,327,954 | $11,400 | $21,327,954 |
| John J. Trizzino John J. Trizzino | 2019 | $390,701 | $1,465,602 | $584,103 | $1,465,602 | $9,546 | $1,465,602 |
| John J. Trizzino John J. Trizzino | 2018 | $378,078 | $1,329,776 | $890,700 | $1,329,776 | $7,500 | $1,329,776 |
| John A. Herrmann III John A. Herrmann III | 2020 | $402,842 | $20,606,814 | $18,924,907 | $20,606,814 | $11,400 | $20,606,814 |
| John A. Herrmann III John A. Herrmann III | 2019 | $378,591 | $1,353,416 | $488,397 | $1,353,416 | $11,200 | $1,353,416 |
| John A. Herrmann III John A. Herrmann III | 2018 | $362,695 | $1,137,576 | $712,560 | $1,137,576 | $11,000 | $1,137,576 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1000694/000110465921060332/tm212692d3_def14a.htm
Novavax Inc Insider Trading
- The most recent transaction was 12,500 units sold on April 4, 2022 by James Young worth over $919.76K
- In the last 19 years, insiders at Novavax Inc sold an estimated value of $286.68M and bought an estimated value of $38.15M
- The most active traders are Gregory Glenn, President, Gary Evans, Director, and John A. Herrmann III, EVP
- Insider trading is most common in March, with the busiest year in 2021
NOVAVAX INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||